Skip to main content
. 2024 Feb 27;15:1330362. doi: 10.3389/fpsyg.2024.1330362

Table 1.

Sample characteristics and comparison of treatment conditions.

Total (N = 359) CBT (n = 179) HT (n = 180)
Sex assigned at birth, n (%) women 215 (59.9) 101 (56.4) 114 (63.3)
Age (in years) 43.07 (12.52) 43.28 (12.18) 42.86 (12.88)
Smoking intensity (cigarettes/day) 19.75 (6.86) 20.35 (6.85) 19.15 (6.83)
Smoking duration (in years) 26.54 (12.36) 26.76 (12.17) 26.32 (12.57)
Age at the start of smoking (in years) 16.53 (3.00) 16.53 (2.98) 16.54 (3.04)
Level of nicotine dependence (FTND, N = 317) 6.02 (1.71) 6.13 (1.70) 5.91 (1.72)
“How important is it to you to become smoke-free at the moment?” (MQ) 8.54 (1.57) 8.45 (1.68) 8.62 (1.45)
“How confident are you that you can achieve this?” (MQ) 6.12 (1.98) 5.93 (2.09) 6.29 (1.86)
“How high would you rate the general efficacy of CBT?” (STEQ) 6.28 (1.77) 6.28 (1.79) 6.28 (1.75)
“How high would you rate the general efficacy of HT?” (STEQ) 6.88 (1.91) 6.74 (1.92) 7.03 (1.90)
Hypnotic suggestibility (HGSHSA) 6.68 (2.47) 6.53 (2.54) 6.83 (2.39)
Total (N = 249) CBT (n = 140) HT (n = 109)
n (%) n (%) n (%)
Previous smoking cessation attempts, n (%) yes 318 (88.6) 160 (89.4) 158 (87.8)
Preference for HT 175 97 78
Preference for CBT 31 19 12
No preference 43 24 19

Mean values and standard deviations are shown unless otherwise stated. FTND, Fagerström test for Nicotine dependence; MQ, motivation questionnaire, answered on a 10-point Likert scale (1 = not at all, 10 = very); STEQ, the subjective treatment efficacy questionnaire (1 = not at all, 10 = very); HGSHS-A, Harvard group scale of hypnotic susceptibility – Form A. All n.s.